Aims: Percutaneous implantation has already been used clinically and is a great option for treating young patients. The use of autologous tissue-engineered valved stents might solve the problem of degeneration and limited durability of biological heart valves.
Methods And Results: Porcine pulmonary heart valves and small intestinal submucosa were obtained from a slaughterhouse. The intestinal submucosa was used to cover the inside of the porcine pulmonary valved stents. Endothelial cells (ECs) and autologous myofibroblasts (MFs) were used from carotid artery segments of juvenile sheep. After MF seeding, constructs were placed in a dynamic bioreactor system and cultured for 16 days. After additional EC seeding, tissue-engineered valved stents were percutaneously deployed into the annulus of the pulmonary valve (n = 9). Angiography was performed at implantation and 4-week follow-up. Constructs were analysed radiographically, by post-mortem examination, and microscopically. In all but one case, orthotopic positioning of the stents (n = 6) at the time of implantation and explantation was observed angiographically, macroscopically, and by computer tomography scan and demonstrated normal valve function (n = 7). Gross morphology confirmed excellent opening and closure characteristics of all leaflets after 4 weeks (n = 7). Strong expression of α-smooth muscle actin in neo-interstitial cells and of von Willebrand factor and PECAM-1 in ECs was revealed by immunocytochemistry.
Conclusion: Good functioning and morphological characteristics were observed after percutaneous tissue-engineered valved stent implantation with autologous cells. This implantation of autologous tissue-engineered valved stents will become a valid future option in adolescents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cvr/cvq212 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells.
Bioact Mater
March 2025
Institute for Mechanobiology, Department of Bioengineering, College of Engineering, Northeastern University, Boston, MA, 02115, USA.
The technology of induced pluripotent stem cells (iPSCs) has enabled the conversion of somatic cells into primitive undifferentiated cells via reprogramming. This approach provides possibilities for cell replacement therapies and drug screening, but the potential risk of tumorigenesis hampers its further development and application. How to generate differentiated cells such as valvular endothelial cells (VECs) has remained a major challenge.
View Article and Find Full Text PDFNew Insights on the Formation of the Mitral Valve Chordae Tendineae in Fetal Life.
J Cardiovasc Dev Dis
November 2024
School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada.
There is an increasing understanding that some mitral valve pathologies have developmental origins. The time course of valvulogenesis varies by animal model; in cattle, the branched chordae tendineae architecture becomes fully developed at full term. The mechanism by which chordae tendineae bifurcate during fetal development remains unknown.
View Article and Find Full Text PDFApplication of right ventricular to pulmonary valved conduit in the surgical treatment of congenital heart disease.
Cardiol Young
July 2024
Department of Cardiovascular Surgery, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.
Article Synopsis
- Pulmonary valve replacement and right ventricular outflow tract reconstruction in children with congenital heart disease (CHD) have seen advancements, particularly in right ventricular outflow tract technology since the first procedure in 1964.
- Valved homograft conduits (VHC) offer significant benefits, including better hemodynamics and less need for lifelong anticoagulation, making them ideal for these surgeries, although donor shortages have led to alternatives like polytetrafluoroethylene conduits.
- Emerging tissue engineering technologies aim to create patient-specific valved conduits using recipient cells, which could eliminate issues like immune rejection and the need for growth adjustments as children develop.
Folic acid modified silver nanoparticles promote endothelialization and inhibit calcification of decellularized heart valves by immunomodulation with anti-bacteria property.
Biomater Adv
January 2025
Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Centre for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, China. Electronic address:
Xenogeneic decellularized heart valves (DHVs) have become one of the most commonly used scaffolds for tissue engineered heart valves (TEHVs) due to extensive resources and possessing the distinct three-layer structure similar to native heart valves. However, DHVs as scaffolds face the shortages such as poor mechanical properties, proneness to thrombosis and calcification, difficulty in endothelialization and chronic inflammatory responses etc., which limit their applications in clinic.
View Article and Find Full Text PDFNovel Bioreactor Design for Non-invasive Longitudinal Monitoring of Tissue-Engineered Heart Valves in 7T MRI and Ultrasound.
Ann Biomed Eng
October 2024
Department of Biohybrid & Medical Textile (BioTex), Center for Biohybrid Medical Systems (CBMS), Institute for Applied Medical Engineering, RWTH Aachen University, Forckenbeckstr. 55, 52074, Aachen, Germany.
The development of cardiovascular implants is abundant, yet their clinical adoption remains a significant challenge in the treatment of valvular diseases. Tissue-engineered heart valves (TEHV) have emerged as a promising solution due to their remodeling capabilities, which have been extensively studied in recent years. However, ensuring reproducible production and clinical translation of TEHV requires robust longitudinal monitoring methods.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!